Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis

Am J Physiol. 1998 Mar;274(3):F580-6. doi: 10.1152/ajprenal.1998.274.3.F580.

Abstract

Ureteral obstruction causes infiltration of the kidney by monocytes/macrophages. This infiltrate is significantly reduced by administration of an angiotensin-converting enzyme (ACE) inhibitor but not by a specific angiotensin II type 1 receptor (AT1 receptor) antagonist. Chemoattractants and cell surface adhesive molecules mediate monocyte/macrophage infiltration. Rats with unilateral ureteral obstruction (UUO) of 1, 3, or 5 days duration were untreated or given enalapril or SC-51316 in the drinking water. We measured the mRNA levels of monocyte chemoatactic peptide 1 (MCP-1), a chemoattractant, and levels of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1), two cell surface adhesion proteins. MCP-1 mRNA increased significantly after 1 day of UUO and increased further through 5 days of UUO in the obstructed kidney. ICAM-1 mRNA also increased significantly after 1 day but steadily declined through 5 days of UUO in the obstructed kidney. VCAM-1 mRNA did not increase significantly until after 3 days of UUO and increased further through 5 days of obstruction. Enalapril or SC-51316 treatment had no significant effect on ICAM-1 mRNA levels. MCP-1 mRNA levels were reduced but remained significantly elevated. Enalapril significantly blunted the increase in VCAM-1 mRNA levels and VCAM-1 protein determined by immunocytochemistry; SC-51316 had no significant effect. Thus changes in VCAM-1 levels may account for the differential effect of enalapril and SC-51316 on monocyte/macrophage infiltration of the kidney during ureteral obstruction.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Animals
  • Cell Adhesion
  • Cell Adhesion Molecules / biosynthesis
  • Chemokine CCL2 / biosynthesis*
  • Enalapril / pharmacology
  • Female
  • Gene Expression Regulation / drug effects
  • Immunohistochemistry
  • Intercellular Adhesion Molecule-1 / biosynthesis*
  • Macrophages / cytology
  • Monocytes / cytology
  • RNA, Messenger / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Tetrazoles / pharmacology
  • Triazoles / pharmacology
  • Ureteral Obstruction / physiopathology
  • Vascular Cell Adhesion Molecule-1 / biosynthesis*

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Cell Adhesion Molecules
  • Chemokine CCL2
  • RNA, Messenger
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Tetrazoles
  • Triazoles
  • Vascular Cell Adhesion Molecule-1
  • Intercellular Adhesion Molecule-1
  • SC 51316
  • Enalapril